The Definitive Forum Uniting Industry & Academia to Spearhead Innate Immunity Development
The 10th Annual Innate Killer Summit united industry pioneers to reveal long-anticipated clinical data, critical advancements in cryopreservation, novel NK engagers and more!
Attendees were able to learn and connect with pioneers including Artiva Bio, Indapta Therapeutics, Genentech, Immunity Bio and Takeda, as they picked up pace to develop life-changing off-the-shelf therapies for cancer, autoimmune disease, and infectious disease.
Insight into NK Assets by Therapeutic Class
Developed by our intelligence team, this graph shows all the NK assets by therapeutic class.
Based on the proportion of different developers in the whole NK industry you can see the likely proportion of focus that was in the room!
Get in touch here to access further information and statistics on the NK space.
ACCESS THE LIST OF 2025 SESSIONS HERE
What You Missed at the 10th Annual Innate Killer Summit:
Explore the applications of NK biology to autoimmune disease by understanding preliminary safety and mechanisms with Artiva Bio and Century Therapeutics
Dive into NK engineering with insights from the latest advances, including innovative CAR designs and gene editing techniques with Katy Rezvani’s Lab and NKILT Therapeutics
Leverage combination approaches to enhance persistence, proliferation and potency of NK cells with Genentech and Indaptus Therapeutics
Review case studies that showcase the real-life applications and impact of NK cell therapies, with detailed presentations from NKore Biotherapeutics and INmune Bio
Discover the versatility of NK cells and how they can be leveraged to expand into indications such as HIV and hepatitis B with Immunity Bio and the University College London
Who Could You Meet in 2026?
You connected with top NK pioneers across cell therapy, engager, TCR and cytokine approaches all in one room to open doors for partnerships in combination therapies and cross-functional learning as this tight knit community came together to advance innate immunity-based therapies.
Amongst the companies who attended were :
What Did The NK Community Have To Say?
"This summit brings together the best researchers from the field, high quality presentations, networking opportunities, with the companies presenting new tech”
Senior Group Leader, Zelluna Immunotherapy
"An opportunity to exchange, debate and discuss novel approaches to improve our technologies to get to patients faster and more efficiently”
President, Chief Executive Officer & Co-Founder, NKILT Therapeutics